Chemically modified curcumin in periodontal therapy: a scoping review.

Chemically modified curcumin analogues, particularly CMC2.24, demonstrated anti-inflammatory and bone-protective effects in laboratory and animal models of periodontitis, but evidence remains preclinical and human trials are needed before clinical application.

A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.